Particle.news

Download on the App Store

UCLA Medical School Faces Federal Class-Action Lawsuit Over Alleged Race-Based Admissions

The lawsuit, filed by advocacy groups Do No Harm and Students for Fair Admissions, accuses UCLA of violating Supreme Court precedent and state law by using race in admissions decisions.

Image
The David Geffen School of Medicine at UCLA (Google Street View)
Image

Overview

  • A federal class-action lawsuit was filed on May 8, 2025, against UCLA's David Geffen School of Medicine, alleging continued use of race-based admissions practices despite legal prohibitions.
  • The plaintiffs, advocacy groups Do No Harm and Students for Fair Admissions, claim that UCLA's admissions policies intentionally discriminate against white and Asian applicants in favor of Black and Latino candidates.
  • The lawsuit cites statistical evidence showing a decline in white and Asian matriculants from 65.7% in 2020 to 53.7% in 2023, despite these groups making up the majority of applicants.
  • Whistleblowers allege that the admissions committee uses application responses and interviews to identify applicants' race, which is then factored into admissions decisions, contrary to Supreme Court rulings.
  • The Department of Justice and the Department of Health and Human Services are also investigating UCLA and other UC campuses for potential violations of civil rights laws and the 2023 Supreme Court decision banning race-based affirmative action.